Global Cold and Flu Supplement Market Growth (Status and Outlook) 2023-2029

February 2023 | 103 pages | ID: G2EA37966898EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Demand for cold and flu supplements has been increasing among the consumers in order to boost immunity and prevent the occurrences of such diseases. Cold and flu supplements are primarily consumed to enhance the immunity system of the individual. Cold and flu supplements are available in different forms, among them tablet and capsule are the most popular forms.

LPI (LP Information)' newest research report, the “Cold and Flu Supplement Industry Forecast” looks at past sales and reviews total world Cold and Flu Supplement sales in 2022, providing a comprehensive analysis by region and market sector of projected Cold and Flu Supplement sales for 2023 through 2029. With Cold and Flu Supplement sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cold and Flu Supplement industry.

This Insight Report provides a comprehensive analysis of the global Cold and Flu Supplement landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cold and Flu Supplement portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cold and Flu Supplement market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cold and Flu Supplement and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cold and Flu Supplement.

The global Cold and Flu Supplement market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Cold and Flu Supplement is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Cold and Flu Supplement is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Cold and Flu Supplement is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Cold and Flu Supplement players cover Wakunaga of America, Neurobiologix, The Vitamin Shoppe, Klaire Labs, Nordic Naturals, Himalaya Global Holdings, Dr. Willmar Schwabe GmbH, FineVine and Flora, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Cold and Flu Supplement market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
  • Natural Molecules
  • Herbal Extracts
  • Vitamins and Minerals
  • Others
Segmentation by application
  • Online
  • Offline
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Wakunaga of America
  • Neurobiologix
  • The Vitamin Shoppe
  • Klaire Labs
  • Nordic Naturals
  • Himalaya Global Holdings
  • Dr. Willmar Schwabe GmbH
  • FineVine
  • Flora
  • Pfizer
  • GlaxoSmithKline
  • NOW Foods
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cold and Flu Supplement Market Size 2018-2029
  2.1.2 Cold and Flu Supplement Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cold and Flu Supplement Segment by Type
  2.2.1 Natural Molecules
  2.2.2 Herbal Extracts
  2.2.3 Vitamins and Minerals
  2.2.4 Others
2.3 Cold and Flu Supplement Market Size by Type
  2.3.1 Cold and Flu Supplement Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Cold and Flu Supplement Market Size Market Share by Type (2018-2023)
2.4 Cold and Flu Supplement Segment by Application
  2.4.1 Online
  2.4.2 Offline
2.5 Cold and Flu Supplement Market Size by Application
  2.5.1 Cold and Flu Supplement Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Cold and Flu Supplement Market Size Market Share by Application (2018-2023)

3 COLD AND FLU SUPPLEMENT MARKET SIZE BY PLAYER

3.1 Cold and Flu Supplement Market Size Market Share by Players
  3.1.1 Global Cold and Flu Supplement Revenue by Players (2018-2023)
  3.1.2 Global Cold and Flu Supplement Revenue Market Share by Players (2018-2023)
3.2 Global Cold and Flu Supplement Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 COLD AND FLU SUPPLEMENT BY REGIONS

4.1 Cold and Flu Supplement Market Size by Regions (2018-2023)
4.2 Americas Cold and Flu Supplement Market Size Growth (2018-2023)
4.3 APAC Cold and Flu Supplement Market Size Growth (2018-2023)
4.4 Europe Cold and Flu Supplement Market Size Growth (2018-2023)
4.5 Middle East & Africa Cold and Flu Supplement Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Cold and Flu Supplement Market Size by Country (2018-2023)
5.2 Americas Cold and Flu Supplement Market Size by Type (2018-2023)
5.3 Americas Cold and Flu Supplement Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Cold and Flu Supplement Market Size by Region (2018-2023)
6.2 APAC Cold and Flu Supplement Market Size by Type (2018-2023)
6.3 APAC Cold and Flu Supplement Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Cold and Flu Supplement by Country (2018-2023)
7.2 Europe Cold and Flu Supplement Market Size by Type (2018-2023)
7.3 Europe Cold and Flu Supplement Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cold and Flu Supplement by Region (2018-2023)
8.2 Middle East & Africa Cold and Flu Supplement Market Size by Type (2018-2023)
8.3 Middle East & Africa Cold and Flu Supplement Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL COLD AND FLU SUPPLEMENT MARKET FORECAST

10.1 Global Cold and Flu Supplement Forecast by Regions (2024-2029)
  10.1.1 Global Cold and Flu Supplement Forecast by Regions (2024-2029)
  10.1.2 Americas Cold and Flu Supplement Forecast
  10.1.3 APAC Cold and Flu Supplement Forecast
  10.1.4 Europe Cold and Flu Supplement Forecast
  10.1.5 Middle East & Africa Cold and Flu Supplement Forecast
10.2 Americas Cold and Flu Supplement Forecast by Country (2024-2029)
  10.2.1 United States Cold and Flu Supplement Market Forecast
  10.2.2 Canada Cold and Flu Supplement Market Forecast
  10.2.3 Mexico Cold and Flu Supplement Market Forecast
  10.2.4 Brazil Cold and Flu Supplement Market Forecast
10.3 APAC Cold and Flu Supplement Forecast by Region (2024-2029)
  10.3.1 China Cold and Flu Supplement Market Forecast
  10.3.2 Japan Cold and Flu Supplement Market Forecast
  10.3.3 Korea Cold and Flu Supplement Market Forecast
  10.3.4 Southeast Asia Cold and Flu Supplement Market Forecast
  10.3.5 India Cold and Flu Supplement Market Forecast
  10.3.6 Australia Cold and Flu Supplement Market Forecast
10.4 Europe Cold and Flu Supplement Forecast by Country (2024-2029)
  10.4.1 Germany Cold and Flu Supplement Market Forecast
  10.4.2 France Cold and Flu Supplement Market Forecast
  10.4.3 UK Cold and Flu Supplement Market Forecast
  10.4.4 Italy Cold and Flu Supplement Market Forecast
  10.4.5 Russia Cold and Flu Supplement Market Forecast
10.5 Middle East & Africa Cold and Flu Supplement Forecast by Region (2024-2029)
  10.5.1 Egypt Cold and Flu Supplement Market Forecast
  10.5.2 South Africa Cold and Flu Supplement Market Forecast
  10.5.3 Israel Cold and Flu Supplement Market Forecast
  10.5.4 Turkey Cold and Flu Supplement Market Forecast
  10.5.5 GCC Countries Cold and Flu Supplement Market Forecast
10.6 Global Cold and Flu Supplement Forecast by Type (2024-2029)
10.7 Global Cold and Flu Supplement Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Wakunaga of America
  11.1.1 Wakunaga of America Company Information
  11.1.2 Wakunaga of America Cold and Flu Supplement Product Offered
  11.1.3 Wakunaga of America Cold and Flu Supplement Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Wakunaga of America Main Business Overview
  11.1.5 Wakunaga of America Latest Developments
11.2 Neurobiologix
  11.2.1 Neurobiologix Company Information
  11.2.2 Neurobiologix Cold and Flu Supplement Product Offered
  11.2.3 Neurobiologix Cold and Flu Supplement Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Neurobiologix Main Business Overview
  11.2.5 Neurobiologix Latest Developments
11.3 The Vitamin Shoppe
  11.3.1 The Vitamin Shoppe Company Information
  11.3.2 The Vitamin Shoppe Cold and Flu Supplement Product Offered
  11.3.3 The Vitamin Shoppe Cold and Flu Supplement Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 The Vitamin Shoppe Main Business Overview
  11.3.5 The Vitamin Shoppe Latest Developments
11.4 Klaire Labs
  11.4.1 Klaire Labs Company Information
  11.4.2 Klaire Labs Cold and Flu Supplement Product Offered
  11.4.3 Klaire Labs Cold and Flu Supplement Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Klaire Labs Main Business Overview
  11.4.5 Klaire Labs Latest Developments
11.5 Nordic Naturals
  11.5.1 Nordic Naturals Company Information
  11.5.2 Nordic Naturals Cold and Flu Supplement Product Offered
  11.5.3 Nordic Naturals Cold and Flu Supplement Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Nordic Naturals Main Business Overview
  11.5.5 Nordic Naturals Latest Developments
11.6 Himalaya Global Holdings
  11.6.1 Himalaya Global Holdings Company Information
  11.6.2 Himalaya Global Holdings Cold and Flu Supplement Product Offered
  11.6.3 Himalaya Global Holdings Cold and Flu Supplement Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Himalaya Global Holdings Main Business Overview
  11.6.5 Himalaya Global Holdings Latest Developments
11.7 Dr. Willmar Schwabe GmbH
  11.7.1 Dr. Willmar Schwabe GmbH Company Information
  11.7.2 Dr. Willmar Schwabe GmbH Cold and Flu Supplement Product Offered
  11.7.3 Dr. Willmar Schwabe GmbH Cold and Flu Supplement Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Dr. Willmar Schwabe GmbH Main Business Overview
  11.7.5 Dr. Willmar Schwabe GmbH Latest Developments
11.8 FineVine
  11.8.1 FineVine Company Information
  11.8.2 FineVine Cold and Flu Supplement Product Offered
  11.8.3 FineVine Cold and Flu Supplement Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 FineVine Main Business Overview
  11.8.5 FineVine Latest Developments
11.9 Flora
  11.9.1 Flora Company Information
  11.9.2 Flora Cold and Flu Supplement Product Offered
  11.9.3 Flora Cold and Flu Supplement Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Flora Main Business Overview
  11.9.5 Flora Latest Developments
11.10 Pfizer
  11.10.1 Pfizer Company Information
  11.10.2 Pfizer Cold and Flu Supplement Product Offered
  11.10.3 Pfizer Cold and Flu Supplement Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Pfizer Main Business Overview
  11.10.5 Pfizer Latest Developments
11.11 GlaxoSmithKline
  11.11.1 GlaxoSmithKline Company Information
  11.11.2 GlaxoSmithKline Cold and Flu Supplement Product Offered
  11.11.3 GlaxoSmithKline Cold and Flu Supplement Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 GlaxoSmithKline Main Business Overview
  11.11.5 GlaxoSmithKline Latest Developments
11.12 NOW Foods
  11.12.1 NOW Foods Company Information
  11.12.2 NOW Foods Cold and Flu Supplement Product Offered
  11.12.3 NOW Foods Cold and Flu Supplement Revenue, Gross Margin and Market Share (2018-2023)
  11.12.4 NOW Foods Main Business Overview
  11.12.5 NOW Foods Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Cold and Flu Supplement Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Natural Molecules
Table 3. Major Players of Herbal Extracts
Table 4. Major Players of Vitamins and Minerals
Table 5. Major Players of Others
Table 6. Cold and Flu Supplement Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Cold and Flu Supplement Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Cold and Flu Supplement Market Size Market Share by Type (2018-2023)
Table 9. Cold and Flu Supplement Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Cold and Flu Supplement Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Cold and Flu Supplement Market Size Market Share by Application (2018-2023)
Table 12. Global Cold and Flu Supplement Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Cold and Flu Supplement Revenue Market Share by Player (2018-2023)
Table 14. Cold and Flu Supplement Key Players Head office and Products Offered
Table 15. Cold and Flu Supplement Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Cold and Flu Supplement Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Cold and Flu Supplement Market Size Market Share by Regions (2018-2023)
Table 20. Global Cold and Flu Supplement Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Cold and Flu Supplement Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Cold and Flu Supplement Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Cold and Flu Supplement Market Size Market Share by Country (2018-2023)
Table 24. Americas Cold and Flu Supplement Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Cold and Flu Supplement Market Size Market Share by Type (2018-2023)
Table 26. Americas Cold and Flu Supplement Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Cold and Flu Supplement Market Size Market Share by Application (2018-2023)
Table 28. APAC Cold and Flu Supplement Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Cold and Flu Supplement Market Size Market Share by Region (2018-2023)
Table 30. APAC Cold and Flu Supplement Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Cold and Flu Supplement Market Size Market Share by Type (2018-2023)
Table 32. APAC Cold and Flu Supplement Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Cold and Flu Supplement Market Size Market Share by Application (2018-2023)
Table 34. Europe Cold and Flu Supplement Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Cold and Flu Supplement Market Size Market Share by Country (2018-2023)
Table 36. Europe Cold and Flu Supplement Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Cold and Flu Supplement Market Size Market Share by Type (2018-2023)
Table 38. Europe Cold and Flu Supplement Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Cold and Flu Supplement Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Cold and Flu Supplement Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Cold and Flu Supplement Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Cold and Flu Supplement Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Cold and Flu Supplement Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Cold and Flu Supplement Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Cold and Flu Supplement Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Cold and Flu Supplement
Table 47. Key Market Challenges & Risks of Cold and Flu Supplement
Table 48. Key Industry Trends of Cold and Flu Supplement
Table 49. Global Cold and Flu Supplement Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Cold and Flu Supplement Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Cold and Flu Supplement Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Cold and Flu Supplement Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Wakunaga of America Details, Company Type, Cold and Flu Supplement Area Served and Its Competitors
Table 54. Wakunaga of America Cold and Flu Supplement Product Offered
Table 55. Wakunaga of America Cold and Flu Supplement Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Wakunaga of America Main Business
Table 57. Wakunaga of America Latest Developments
Table 58. Neurobiologix Details, Company Type, Cold and Flu Supplement Area Served and Its Competitors
Table 59. Neurobiologix Cold and Flu Supplement Product Offered
Table 60. Neurobiologix Main Business
Table 61. Neurobiologix Cold and Flu Supplement Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Neurobiologix Latest Developments
Table 63. The Vitamin Shoppe Details, Company Type, Cold and Flu Supplement Area Served and Its Competitors
Table 64. The Vitamin Shoppe Cold and Flu Supplement Product Offered
Table 65. The Vitamin Shoppe Main Business
Table 66. The Vitamin Shoppe Cold and Flu Supplement Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. The Vitamin Shoppe Latest Developments
Table 68. Klaire Labs Details, Company Type, Cold and Flu Supplement Area Served and Its Competitors
Table 69. Klaire Labs Cold and Flu Supplement Product Offered
Table 70. Klaire Labs Main Business
Table 71. Klaire Labs Cold and Flu Supplement Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Klaire Labs Latest Developments
Table 73. Nordic Naturals Details, Company Type, Cold and Flu Supplement Area Served and Its Competitors
Table 74. Nordic Naturals Cold and Flu Supplement Product Offered
Table 75. Nordic Naturals Main Business
Table 76. Nordic Naturals Cold and Flu Supplement Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Nordic Naturals Latest Developments
Table 78. Himalaya Global Holdings Details, Company Type, Cold and Flu Supplement Area Served and Its Competitors
Table 79. Himalaya Global Holdings Cold and Flu Supplement Product Offered
Table 80. Himalaya Global Holdings Main Business
Table 81. Himalaya Global Holdings Cold and Flu Supplement Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Himalaya Global Holdings Latest Developments
Table 83. Dr. Willmar Schwabe GmbH Details, Company Type, Cold and Flu Supplement Area Served and Its Competitors
Table 84. Dr. Willmar Schwabe GmbH Cold and Flu Supplement Product Offered
Table 85. Dr. Willmar Schwabe GmbH Main Business
Table 86. Dr. Willmar Schwabe GmbH Cold and Flu Supplement Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Dr. Willmar Schwabe GmbH Latest Developments
Table 88. FineVine Details, Company Type, Cold and Flu Supplement Area Served and Its Competitors
Table 89. FineVine Cold and Flu Supplement Product Offered
Table 90. FineVine Main Business
Table 91. FineVine Cold and Flu Supplement Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. FineVine Latest Developments
Table 93. Flora Details, Company Type, Cold and Flu Supplement Area Served and Its Competitors
Table 94. Flora Cold and Flu Supplement Product Offered
Table 95. Flora Main Business
Table 96. Flora Cold and Flu Supplement Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Flora Latest Developments
Table 98. Pfizer Details, Company Type, Cold and Flu Supplement Area Served and Its Competitors
Table 99. Pfizer Cold and Flu Supplement Product Offered
Table 100. Pfizer Main Business
Table 101. Pfizer Cold and Flu Supplement Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Pfizer Latest Developments
Table 103. GlaxoSmithKline Details, Company Type, Cold and Flu Supplement Area Served and Its Competitors
Table 104. GlaxoSmithKline Cold and Flu Supplement Product Offered
Table 105. GlaxoSmithKline Cold and Flu Supplement Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. GlaxoSmithKline Main Business
Table 107. GlaxoSmithKline Latest Developments
Table 108. NOW Foods Details, Company Type, Cold and Flu Supplement Area Served and Its Competitors
Table 109. NOW Foods Cold and Flu Supplement Product Offered
Table 110. NOW Foods Main Business
Table 111. NOW Foods Cold and Flu Supplement Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. NOW Foods Latest Developments

LIST OF FIGURES

Figure 1. Cold and Flu Supplement Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cold and Flu Supplement Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Cold and Flu Supplement Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Cold and Flu Supplement Sales Market Share by Country/Region (2022)
Figure 8. Cold and Flu Supplement Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Cold and Flu Supplement Market Size Market Share by Type in 2022
Figure 10. Cold and Flu Supplement in Online
Figure 11. Global Cold and Flu Supplement Market: Online (2018-2023) & ($ Millions)
Figure 12. Cold and Flu Supplement in Offline
Figure 13. Global Cold and Flu Supplement Market: Offline (2018-2023) & ($ Millions)
Figure 14. Global Cold and Flu Supplement Market Size Market Share by Application in 2022
Figure 15. Global Cold and Flu Supplement Revenue Market Share by Player in 2022
Figure 16. Global Cold and Flu Supplement Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Cold and Flu Supplement Market Size 2018-2023 ($ Millions)
Figure 18. APAC Cold and Flu Supplement Market Size 2018-2023 ($ Millions)
Figure 19. Europe Cold and Flu Supplement Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Cold and Flu Supplement Market Size 2018-2023 ($ Millions)
Figure 21. Americas Cold and Flu Supplement Value Market Share by Country in 2022
Figure 22. United States Cold and Flu Supplement Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Cold and Flu Supplement Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Cold and Flu Supplement Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Cold and Flu Supplement Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Cold and Flu Supplement Market Size Market Share by Region in 2022
Figure 27. APAC Cold and Flu Supplement Market Size Market Share by Type in 2022
Figure 28. APAC Cold and Flu Supplement Market Size Market Share by Application in 2022
Figure 29. China Cold and Flu Supplement Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Cold and Flu Supplement Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Cold and Flu Supplement Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Cold and Flu Supplement Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Cold and Flu Supplement Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Cold and Flu Supplement Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Cold and Flu Supplement Market Size Market Share by Country in 2022
Figure 36. Europe Cold and Flu Supplement Market Size Market Share by Type (2018-2023)
Figure 37. Europe Cold and Flu Supplement Market Size Market Share by Application (2018-2023)
Figure 38. Germany Cold and Flu Supplement Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Cold and Flu Supplement Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Cold and Flu Supplement Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Cold and Flu Supplement Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Cold and Flu Supplement Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Cold and Flu Supplement Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Cold and Flu Supplement Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Cold and Flu Supplement Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Cold and Flu Supplement Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Cold and Flu Supplement Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Cold and Flu Supplement Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Cold and Flu Supplement Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Cold and Flu Supplement Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 52. APAC Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 53. Europe Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 55. United States Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 56. Canada Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 59. China Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 60. Japan Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 61. Korea Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 63. India Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 64. Australia Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 65. Germany Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 66. France Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 67. UK Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 68. Italy Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 69. Russia Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 70. Spain Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 73. Israel Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Cold and Flu Supplement Market Size 2024-2029 ($ Millions)
Figure 76. Global Cold and Flu Supplement Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Cold and Flu Supplement Market Size Market Share Forecast by Application (2024-2029)